title: Effects of asymmetric dimethylarginine on bovine retinal capillary endothelial cell proliferation, reactive oxygen species production, permeability, intercellular adhesion molecule-1, and occludin expression.
abstract: OBJECTIVE
  Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase, is associated with impaired endothelial dysfunction, such as chronic heart failure, hypertension, diabetes, and pulmonary hypertension. The effects of ADMA on cell proliferation, reactive oxygen species (ROS) production, cell permeability, intercellular adhesion molecule-1 (ICAM-1), and tight-junction protein occludin levels in bovine retinal capillary endothelial cells (BRCECs) were investigated.
  
  
  METHODS
  A cell proliferation assay was performed using the novel tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and an electron coupling reagent. Intracellular ROS levels were determined using the fluorescent probe CM-H(2)DCFDA. Horseradish peroxidase was used for a permeability assay. ICAM-1 and tight-junction protein occludin were assessed by western blotting and quantitative real-time PCR.
  
  
  RESULTS
  Cell proliferation was significantly inhibited by ADMA. ADMA increased intracellular ROS generation in BRCECs. The increased ROS production induced by ADMA was markedly inhibited by the angiotensin II receptor-blocker telmisartan, the angiotensin-converting enzyme inhibitor benazepril, the reduced form of nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase inhibitor diphenyliodonium (DPI), or the antioxidant and free-radical scavenger N-acetyl-L-cysteine (NAC). ADMA significantly increased horseradish peroxidase (HRP) permeability in BRCECs. Benazepril, telmisartan, DPI, and NAC downregulated cell permeability. ADMA markedly upregulated ICAM-1 expression in BRCECs, which were downregulated by telmisartan, DPI, and NAC. ADMA significantly downregulated occludin expression in BRCECs. Benazepril and telmisartan upregulated occludin expression in BRCECs exposed to ADMA.
  
  
  CONCLUSIONS
  Our results provide the first reported evidence that ADMA has potent adverse effects on cell proliferation, intracellular ROS generation, cell permeability, levels of ICAM-1, and the tight-junction protein occludin. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and antioxidants are effective inhibitors of the adverse effects of ADMA.
authors.affiliation: Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai Jiaotong University, Shanghai, China.
authors.forename: Yi-Hui
authors.initials: YH
authors.lastname: Chen
authors.forename: Xun
authors.initials: X
authors.lastname: Xu
authors.forename: Min-Jie
authors.initials: MJ
authors.lastname: Sheng
authors.forename: Zhi
authors.initials: Z
authors.lastname: Zheng
authors.forename: Qing
authors.initials: Q
authors.lastname: Gu
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D001120:Arginine / Q000031:analogs & derivatives* / Q000494:pharmacology; D015153:Blotting, Western; D002417:Cattle; D049109:Cell Proliferation; D042783:Endothelial Cells / Q000166:cytology* / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis / Q000378:metabolism; D008565:Membrane Proteins / Q000096:biosynthesis; D062793:Occludin; D010539:Permeability; D017382:Reactive Oxygen Species; D012171:Retinal Vessels / Q000166:cytology / Q000187:drug effects; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019108:Tight Junctions
chemical_list: D000975:Antioxidants; D004791:Enzyme Inhibitors; D008565:Membrane Proteins; D062793:Occludin; D017382:Reactive Oxygen Species; D018799:Intercellular Adhesion Molecule-1; C018524:N,N-dimethylarginine; D001120:Arginine